MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.medcli.2026.107545

Медицинская библиотека · Medicina clinica · 2026

Comparative efficacy and safety of rosuvastatin versus atorvastatin after acute ischemic stroke or transient ischemic attack: A systematic review and exploratory meta-analysis.

Cueva-Cañola Luis E, Beltran-De la Fuente Andrea C, Ramírez Navarro Diana I, Carrión-Cuéllar Astrid G, Navarro-Rondoy Bruno J, Alberca-Naira Yerson, Mendoza Castillo Bruno, Jimenez-Alvarez Harold, Zuñiga-Montaño Karoly P, Calvario-Sanchez Erick N, Rangel-Castilla Leonardo

СтатьяОбзорПеревод в очереди

Аннотация

BACKGROUND AND

OBJECTIVE

Acute ischemic stroke (AIS) and transient ischemic attack (TIA) are leading causes of mortality and disability. High-intensity statins are central to secondary prevention, with guidelines recommending atorvastatin or rosuvastatin; however, comparative evidence post-stroke is limited. This study systematically reviewed literature comparing both agents after AIS/TIA.

MATERIAL AND

METHODS

The protocol was registered in PROSPERO (CRD420261287374). PubMed, Embase, and Ovid MEDLINE were searched from inception to January 17, 2026, using predefined terms for statins and AIS/TIA.

RESULTS

Five studies were included (one randomized trial and four cohort studies). Compared with atorvastatin, rosuvastatin was associated with greater improvements in lipid and inflammatory markers. Despite these differences, rates of recurrent stroke and all-cause mortality were similar between treatments. However, rosuvastatin was associated with lower rates of hemorrhagic stroke and more favorable composite cardiovascular outcomes.

CONCLUSIONS

Evidence suggests biological differences but is insufficient to establish clinical superiority of either statin.

Для цитирования: Cueva-Cañola Luis E, Beltran-De la Fuente Andrea C, Ramírez Navarro Diana I, Carrión-Cuéllar Astrid G, Navarro-Rondoy Bruno J, Alberca-Naira Yerson, Mendoza Castillo Bruno, Jimenez-Alvarez Harold, Zuñiga-Montaño Karoly P, Calvario-Sanchez Erick N, Rangel-Castilla Leonardo. Comparative efficacy and safety of rosuvastatin versus atorvastatin after acute ischemic stroke or transient ischemic attack: A systematic review and exploratory meta-analysis.. Medicina clinica. 2026. DOI: 10.1016/j.medcli.2026.107545.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.